Quadrant Capital Group’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-314
Closed -$2.4K 2270
2026
Q1
$2.4K Sell
314
-78
-20% -$596 ﹤0.01% 2480
2025
Q4
$3.81K Buy
392
+327
+503% +$2.78K ﹤0.01% 2422
2025
Q3
$273 Buy
+65
New +$415 ﹤0.01% 2642
2025
Q2
Sell
-2,104
Closed -$20.5K 2314
2025
Q1
$20.5K Buy
2,104
+148
+8% +$1.83K ﹤0.01% 2024
2024
Q4
$23.7K Hold
1,956
﹤0.01% 1813
2024
Q3
$21.4K Buy
1,956
+66
+3% +$670 ﹤0.01% 1864
2024
Q2
$17K Sell
1,890
-815
-30% -$5.68K ﹤0.01% 1923
2024
Q1
$22.1K Buy
2,705
+1,868
+223% +$15.3K ﹤0.01% 1810
2023
Q4
$7.06K Buy
837
+793
+1,802% +$9.19K ﹤0.01% 2187
2023
Q3
$753 Hold
44
﹤0.01% 2522
2023
Q2
$1.02K Buy
+44
New +$860 ﹤0.01% 2494

Other funds holding REPL

Quadrant Capital Group's REPL Position: Q2 2026 in Review

Quadrant Capital Group sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 314 shares — an estimated $2.4K sold.

Quadrant Capital Group first reported a position in REPL in Q2 2023 and held it in 11 quarters. The position peaked at $23.7K in Q4 2024. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Quadrant Capital Group reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 314 Replimune Group shares in Q2 2026, an estimated $2.4K.
  • Quadrant Capital Group first reported a position in Replimune Group in Q2 2023 and held it in 11 quarters.
  • Quadrant Capital Group's Replimune Group position peaked at $23.7K in Q4 2024.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.